175 related articles for article (PubMed ID: 17447523)
1. [Paradigm shift in clinical trials for neurodegenerative diseases].
Katsuno M; Banno H; Suzuki K; Takeuchi Y; Sobue G
Brain Nerve; 2007 Apr; 59(4):367-74. PubMed ID: 17447523
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA).
Katsuno M; Adachi H; Waza M; Banno H; Suzuki K; Tanaka F; Doyu M; Sobue G
Exp Neurol; 2006 Jul; 200(1):8-18. PubMed ID: 16513111
[TBL] [Abstract][Full Text] [Related]
3. [Animal models of neurodegenerative diseases on the road to disease-modifying therapy: spinal and bulbar muscular atrophy].
Sobue G
Rinsho Shinkeigaku; 2007 Nov; 47(11):941-3. PubMed ID: 18210842
[TBL] [Abstract][Full Text] [Related]
4. [Molecular-targeted therapy for neurodegenerative diseases].
Sobue G
Rinsho Shinkeigaku; 2009 Nov; 49(11):747-9. PubMed ID: 20030200
[TBL] [Abstract][Full Text] [Related]
5. [Disease-modifying therapy for spinal and bulbar muscular atrophy (SBMA)].
Suzuki K; Banno H; Katsuno M; Adachi H; Tanaka F; Sobue G
Brain Nerve; 2012 Mar; 64(3):237-44. PubMed ID: 22402717
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis-targeting therapeutics for spinal and bulbar muscular atrophy (SBMA).
Suzuki K; Kastuno M; Banno H; Sobue G
Neuropathology; 2009 Aug; 29(4):509-16. PubMed ID: 19486304
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy.
Adachi H; Waza M; Katsuno M; Tanaka F; Doyu M; Sobue G
Neuropathol Appl Neurobiol; 2007 Apr; 33(2):135-51. PubMed ID: 17359355
[TBL] [Abstract][Full Text] [Related]
8. [Molecular pathogenesis of motor neuron diseases].
Sobue G
Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Feb; 21(1):21-25. PubMed ID: 11400322
[TBL] [Abstract][Full Text] [Related]
9. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy.
Thomas PS; Fraley GS; Damian V; Woodke LB; Zapata F; Sopher BL; Plymate SR; La Spada AR
Hum Mol Genet; 2006 Jul; 15(14):2225-38. PubMed ID: 16772330
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA).
Banno H; Katsuno M; Suzuki K; Tanaka F; Sobue G
Cell Tissue Res; 2012 Jul; 349(1):313-20. PubMed ID: 22476656
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA).
Katsuno M; Tanaka F; Adachi H; Banno H; Suzuki K; Watanabe H; Sobue G
Prog Neurobiol; 2012 Dec; 99(3):246-56. PubMed ID: 22609045
[TBL] [Abstract][Full Text] [Related]
12. Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker.
Banno H; Adachi H; Katsuno M; Suzuki K; Atsuta N; Watanabe H; Tanaka F; Doyu M; Sobue G
Ann Neurol; 2006 Mar; 59(3):520-6. PubMed ID: 16358333
[TBL] [Abstract][Full Text] [Related]
13. Caspase-3 cleaves the expanded androgen receptor protein of spinal and bulbar muscular atrophy in a polyglutamine repeat length-dependent manner.
Kobayashi Y; Miwa S; Merry DE; Kume A; Mei L; Doyu M; Sobue G
Biochem Biophys Res Commun; 1998 Nov; 252(1):145-50. PubMed ID: 9813160
[TBL] [Abstract][Full Text] [Related]
14. Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients.
Atsuta N; Watanabe H; Ito M; Banno H; Suzuki K; Katsuno M; Tanaka F; Tamakoshi A; Sobue G
Brain; 2006 Jun; 129(Pt 6):1446-55. PubMed ID: 16621916
[TBL] [Abstract][Full Text] [Related]
15. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy.
Banno H; Katsuno M; Suzuki K; Takeuchi Y; Kawashima M; Suga N; Takamori M; Ito M; Nakamura T; Matsuo K; Yamada S; Oki Y; Adachi H; Minamiyama M; Waza M; Atsuta N; Watanabe H; Fujimoto Y; Nakashima T; Tanaka F; Doyu M; Sobue G
Ann Neurol; 2009 Feb; 65(2):140-50. PubMed ID: 19259967
[TBL] [Abstract][Full Text] [Related]
16. CAG repeat disorder models and human neuropathology: similarities and differences.
Yamada M; Sato T; Tsuji S; Takahashi H
Acta Neuropathol; 2008 Jan; 115(1):71-86. PubMed ID: 17786457
[TBL] [Abstract][Full Text] [Related]
17. Huntingtin-associated protein 1 (HAP1) interacts with androgen receptor (AR) and suppresses SBMA-mutant-AR-induced apoptosis.
Takeshita Y; Fujinaga R; Zhao C; Yanai A; Shinoda K
Hum Mol Genet; 2006 Aug; 15(15):2298-312. PubMed ID: 16782802
[TBL] [Abstract][Full Text] [Related]
18. CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA.
Suzuki K; Katsuno M; Banno H; Takeuchi Y; Atsuta N; Ito M; Watanabe H; Yamashita F; Hori N; Nakamura T; Hirayama M; Tanaka F; Sobue G
Brain; 2008 Jan; 131(Pt 1):229-39. PubMed ID: 18056738
[TBL] [Abstract][Full Text] [Related]
19. [Clinical manifestations and molecular genetics of spinal bulbar muscular atrophy: report of 5 cases].
Li XH; Zhuang JJ; Xie QY; Li AP; Liang XL; Feng YQ; Fang YY; Li JR; Liang YX
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1611-5. PubMed ID: 17803850
[TBL] [Abstract][Full Text] [Related]
20. Pure bulbar motor neuron involvement linked to an abnormal CAG repeat expansion in the androgen receptor gene.
Praline J; Guennoc AM; Malinge MC; de Toffol B; Corcia P
Amyotroph Lateral Scler; 2008 Feb; 9(1):40-2. PubMed ID: 17852020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]